Studies on the mechanism of resistance to rapamycin in human cancer cells.
about
Signaling by target of rapamycin proteins in cell growth controlElucidating TOR signaling and rapamycin action: lessons from Saccharomyces cerevisiae.Rapamycin potentiates transforming growth factor beta-induced growth arrest in nontransformed, oncogene-transformed, and human cancer cells.Expression of constitutively active 4EBP-1 enhances p27Kip1 expression and inhibits proliferation of MCF7 breast cancer cellsDynamic aberrant NF-κB spurs tumorigenesis: a new model encompassing the microenvironmentEnhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR.Rapamycin response in tumorigenic and non-tumorigenic hepatic cell linesThe physiology and pathophysiology of rapamycin resistance: implications for cancerc-myc Repression of TSC2 contributes to control of translation initiation and Myc-induced transformationRapidly reversible manipulation of molecular activity with dual chemical dimerizersThe yeast Tor signaling pathway is involved in G2/M transition via polo-kinase.Phase 2 trial of erlotinib plus sirolimus in adults with recurrent glioblastoma.Preclinical evaluation of the combination of mTOR and proteasome inhibitors with radiotherapy in malignant peripheral nerve sheath tumorsGrowth controls connect: interactions between c-myc and the tuberous sclerosis complex-mTOR pathway.An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity in Pten+/- mice.A role of the kinase mTOR in cellular transformation induced by the oncoproteins P3k and Akt.Response to mTOR inhibition: activity of eIF4E predicts sensitivity in cell lines and acquired changes in eIF4E regulation in breast cancer.Coibamide A induces mTOR-independent autophagy and cell death in human glioblastoma cells.Phase I study of temsirolimus in pediatric patients with recurrent/refractory solid tumors.A set of imprinted genes required for normal body growth also promotes growth of rhabdomyosarcoma cells.Oncogenic features of the bone morphogenic protein 7 (BMP7) in pheochromocytoma.The effect of rapamycin on DNA synthesis in multiple tissues from late gestation fetal and postnatal ratsHepatic translation control in the late-gestation fetal ratSuperoxide anions regulate TORC1 and its ability to bind Fpr1:rapamycin complex.Brain tumor stem cells as therapeutic targets in models of glioma.mTOR, metabolism, and the regulation of T-cell differentiation and function.Mammalian target of rapamycin complex 1 (mTORC1) enhances bortezomib-induced death in tuberous sclerosis complex (TSC)-null cells by a c-MYC-dependent induction of the unfolded protein response.Differential effects of rapamycin in anti-GBM glomerulonephritis.Synergistic operation of four cis-acting elements mediate high level DAL5 transcription in Saccharomyces cerevisiae.Rapamycin protects testes against germ cell apoptosis and oxidative stress induced by testicular ischemia-reperfusion.A Molecular Cascade Modulates MAP1B and Confers Resistance to mTOR Inhibition in Human Glioblastoma.Rapamycin inhibits ox-LDL-induced inflammation in human endothelial cells in vitro by inhibiting the mTORC2/PKC/c-Fos pathway.
P2860
Q24522447-9EFAAE31-C681-43FD-96E5-93A3B5EEAF5BQ24537557-66FE5052-3CD1-4A10-B435-8D9FFE5132B6Q24538036-AC5896A5-E0A0-41F6-A27A-72D3E69B90CAQ24805438-2997DD03-CAE2-4F4F-80DD-DEBA3A2EAA20Q27025321-F69D625B-97E5-48F1-BAC3-9672D5D91D31Q27824772-E5437D4C-1B23-4496-86FF-3C2E661D23D4Q28476293-19D796B4-0A8F-4807-8EEC-AE38C26E96DCQ28478235-4C6D0601-A6CB-4C6D-86EB-EACEBE7ACB4FQ28573044-611F864D-94AB-4426-8259-EC64A2473DD9Q30564454-4B2DECB4-CD4B-4949-8081-F1D38C52C7B9Q33336423-26FEB52E-CC50-4E81-963F-80D7B0AFC11FQ33747609-BC5C5F23-C4A7-455C-97A1-652248D99262Q33763742-7BAEFA03-5085-47D4-AF08-34E7932E0DB7Q33831975-6252E580-E68F-4D97-B6CF-B8C98706DD4AQ33943166-8410D89F-D96E-4342-A6A8-A819BEACA0EDQ34585873-26CD9499-9022-466B-9383-60A363110197Q34660064-E7C7AA6C-69C2-49FD-9946-9473B67C19FFQ34769744-BE1FAD67-7D9B-47D2-95E2-D6E5F7AA1407Q35112340-87B0A6E8-5DC4-4C98-B044-90C1361DA0C8Q36169619-DCF1CD3D-5EFD-49BD-9E4A-0DDEE95D1686Q36629525-0B605BC9-F93C-439A-B661-4AF6193B51BCQ36842368-112606AA-F9FC-4BDF-B63D-F29407132D00Q36846672-131AC33F-B06E-4306-BE9F-A95DD200D310Q36937229-9F60D82B-5542-4738-B2ED-24050295A990Q37773191-8684026A-FC52-4AE6-8E73-D0697AF125E1Q38034265-B84A33D5-08B6-4151-8B19-0E0755EABDE9Q39161594-EBA7FD5E-D5EA-44BF-BDFF-C046D7FA6EDDQ41066466-D2CAFB92-04BC-417E-93C1-900335C30A92Q42636412-DAF0A5AE-D694-4BB4-AC5E-F5D20C25B1E7Q47115193-5CB57085-CF63-4026-8577-251D9CDCA75BQ47404879-0377B96F-2008-43FF-A9A7-161376C8F638Q47601570-EBC94A7C-8BB8-4245-972D-FDE088CD2E99
P2860
Studies on the mechanism of resistance to rapamycin in human cancer cells.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Studies on the mechanism of resistance to rapamycin in human cancer cells.
@en
type
label
Studies on the mechanism of resistance to rapamycin in human cancer cells.
@en
prefLabel
Studies on the mechanism of resistance to rapamycin in human cancer cells.
@en
P2093
P1476
Studies on the mechanism of resistance to rapamycin in human cancer cells.
@en
P2093
Abraham RT
Dilling MB
Houghton PJ
Lawrence JC Jr
P304
P577
1998-11-01T00:00:00Z